The quick answer
Weight loss—whether from medication, diet, surgery, or other approaches—can include some loss of lean tissue as well as fat. GLP-1-based therapies generally produce substantial fat loss, but body-composition studies also show reductions in lean mass. Lean mass is not the same thing as skeletal muscle, and a change in lean mass does not automatically mean loss of strength or function. The most practical protective strategy is adequate nutrition, sufficient protein, progressive resistance exercise, and clinical monitoring when risk is higher.
Does GLP-1 treatment cause muscle loss?
It is more accurate to say that substantial weight loss can include a reduction in lean mass. Trials of GLP-1 and dual incretin therapies show that most weight lost is fat, but some lean tissue is also lost. Body-composition measurements such as DXA report 'lean mass,' which includes more than skeletal muscle. For that reason, a scan showing lower lean mass should not automatically be interpreted as the same amount of muscle tissue lost or as proof of weaker physical function.
Why preserving muscle matters
- Muscle supports strength, mobility, balance, and independence.
- Resistance exercise and muscle tissue contribute to metabolic health.
- Preserving function matters especially for older adults and people starting with low muscle mass.
- Very low food intake can make it harder to obtain adequate protein, vitamins, and minerals.
- Focusing only on scale weight can miss important changes in strength and body composition.
4 ways to support muscle while losing weight
1. Eat enough protein
Include protein-containing foods in the meals you can tolerate, alongside enough overall nutrition. Your daily amount should reflect your health and needs; the protein guide explains individualized targets and practical food options.
Protein targets and foods for a smaller appetite
2. Do resistance exercise
Resistance training is one of the most important tools for preserving muscle and function during weight loss. Examples include weight machines, free weights, resistance bands, or appropriately programmed body-weight exercises. Beginners, older adults, and people with joint, cardiovascular, or mobility limitations may benefit from professional guidance.
3. Avoid chronically inadequate nutrition
Very low appetite can lead to insufficient calories, protein, and micronutrients. The goal of GLP-1 therapy is not to eat as little as possible. Nutrient-dense meals, appropriate supplementation when clinically indicated, and management of nausea or constipation can help maintain nutritional adequacy.
4. Monitor more than the scale
Weight is useful, but it is not the only outcome. Depending on risk, clinicians may also consider waist circumference, dietary intake, functional measures such as sit-to-stand performance or grip strength, exercise capacity, and body composition. Changes should be interpreted in context rather than chasing a single scan number.
A simple weekly muscle-support framework
| Area | Practical focus |
|---|---|
| Protein | Include a meaningful protein source at meals and snacks as tolerated. |
| Strength | Perform progressive resistance exercise on multiple days per week when medically appropriate. |
| Overall food quality | Prioritize nutrient-dense foods rather than using appetite suppression to skip nutrition. |
| Hydration | Drink enough for your individual needs, especially around activity. |
| Recovery | Allow adequate sleep and recovery between challenging sessions. |
| Monitoring | Pay attention to strength, energy, function, and overly rapid or unintended weight loss. |
Who may need closer monitoring?
- Older adults, particularly those with frailty or low baseline muscle mass.
- People losing weight very rapidly or eating very little.
- People with repeated nausea, vomiting, diarrhea, or other barriers to adequate nutrition.
- People with a history of sarcopenia, significant mobility limitations, or recent hospitalization.
- People with chronic kidney disease or other conditions that complicate protein recommendations.
What about creatine or muscle-building supplements?
Resistance training and adequate nutrition have stronger practical support than relying on supplements. Recent reviews discuss creatine and other supplements as possible adjuncts, but evidence specifically in people using GLP-1 therapies remains limited or indirect. Supplements can also be inappropriate with certain kidney conditions or medications. Discuss them with a clinician or registered dietitian rather than treating them as a substitute for food and training.
Frequently asked questions
Will all the weight I lose on a GLP-1 be fat?
No. As with other forms of meaningful weight loss, changes can include fat mass and lean mass. The proportions vary among individuals and studies.
Is lean mass the same as muscle?
No. Lean mass includes skeletal muscle but also body water, organs, connective tissue, and other non-fat tissues.
Can I preserve muscle without strength training?
Adequate protein helps, but resistance exercise provides a direct stimulus for maintaining strength and muscle. When possible and medically appropriate, combining both is preferable.
Should I stop my GLP-1 if a body-composition scan shows lean-mass loss?
Do not stop or change prescription treatment based on one measurement without discussing it with your clinician. Body-composition methods have limitations, and the result should be interpreted alongside strength, function, nutrition, rate of weight loss, and overall health.
Bring your questions to your care team
Discuss symptoms, nutrition, and treatment tolerance with a licensed clinician. Medication changes should be made with your prescriber.
Explore weight loss care →Sources & medical information
This guide provides general education, not an individualized nutrition plan or medical advice. Protein, fluid, and activity needs vary. Seek medical care for severe or persistent symptoms, and speak with your clinician before changing treatment.
- 2025 joint advisory: Nutritional priorities to support GLP-1 therapy for obesity
- Expert consensus: Nutritional and lifestyle supportive care with GLP-1-based therapies
Learn about our editorial policy and medical review process.
